Viral hepatitis and liver infections remain a significant global health concern despite advances in prevention and treatment. Chronic viral hepatitis can lead to progressive liver disease, cirrhosis, and hepatocellular carcinoma if left untreated. Improved screening, vaccination programs, and highly effective antiviral therapies have dramatically changed disease outcomes. However, challenges remain in access to care, early diagnosis, and managing co-infections. This topic highlights advances in antiviral therapy, public health strategies, and global efforts aimed at disease elimination, while addressing emerging challenges in liver infections and long-term liver health.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China